Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
13 studies found for:    apatinib
Show Display Options
Rank Status Study
1 Completed A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: apatinib;   Drug: placebo
2 Completed A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: Apatinib
3 Active, not recruiting Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients
Condition: Metastatic Breast Cancer
Intervention: Drug: Apatinib
4 Unknown  A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Intervention: Drug: Apatinib
5 Unknown  Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: apatinib;   Drug: placebo
6 Unknown  Study of Apatinib as an Inhibitor of Tumor Angiogenesis
Condition: Tumor
Intervention: Drug: apatinib
7 Recruiting Dose-Escalation and Safety Trial of YN968D1
Condition: Cancer Patients With Solid Tumors
Intervention: Drug: YN968D1
8 Completed Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer
Condition: Gastric Carcinoma
Intervention: Drug: apatinib tablet
9 Not yet recruiting Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Apatinib;   Drug: Placebo
10 Unknown  Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib Tablets in the Treatment of Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Apatinib;   Drug: apatinib
11 Unknown  Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer
Condition: Advanced or Metastatic Gastric Cancer
Interventions: Drug: apatinib;   Drug: placebo
12 Recruiting Study of Apatinib After Systemic Therapy(Chemotherapy and/or Targeted Therapy) in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Apatinib;   Drug: Placebo
13 Unknown  Dose-Escalation and Safety Trial of YN968D1
Condition: Cancer Patients With Solid Tumors
Intervention: Drug: YN968D1

Indicates status has not been verified in more than two years